Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 3/20 | 0.64 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.54 |
| ▸ | NOS3 | P29474 | 2/20 | 0.50 |
| ▸ | NOS1 | P29475 | 2/20 | 0.50 |
| ▸ | NOS2 | P35228 | 2/20 | 0.50 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.50 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.50 |
| ▸ | LOXL2 | Q9Y4K0 | 3/20 | 0.48 |
| ▸ | ABAT | P80404 | 1/20 | 0.46 |
| ▸ | TPSAB1 | Q15661 | 2/20 | 0.42 |
| ▸ | POLB | P06746 | 1/20 | 0.42 |
| ▸ | PSIP1 | O75475 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL30839558 | 0.97 | HRH3 (0.61) | HRH3ALDH1A1TSHRTAAR1NOS3 | |
| Hydrochloric Acid SCHEMBL6433564 | 0.97 | HRH3 (0.61) | HRH3ALDH1A1TSHRTAAR1NOS3 | |
| Benzylamine SCHEMBL28220474 | 0.86 | ALDH1A1 (0.74) | HRH3ALDH1A1TSHRTAAR1NOS1 | |
| Benzylamine SCHEMBL28220473 | 0.86 | ALDH1A1 (0.74) | HRH3ALDH1A1TSHRTAAR1NOS1 | |
| SCHEMBL659509 | 0.86 | HRH3 (0.82) | HRH3ALDH1A1TSHRTAAR1NOS3 | |
| SCHEMBL2464280 | 0.81 | ALDH1A1 (0.54) | HRH3ALDH1A1TSHRTAAR1NOS3 | |
| SCHEMBL4277824 | 0.80 | HRH3 (0.58) | HRH3ALDH1A1TSHRTAAR1NOS3 | |
| SCHEMBL57323 | 0.79 | HRH3 (0.64) | HRH3ALDH1A1TSHRTAAR1NOS3 | |
| SCHEMBL1873058 | 0.79 | ALDH1A1 (0.44) | HRH3ALDH1A1TSHRTAAR1NOS3 | |
| Hydrochloric Acid SCHEMBL3625400 | 0.78 | HRH3 (0.56) | HRH3ALDH1A1TSHRTAAR1NOS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 83 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119144233-A | Non-cured rubber asphalt waterproof coating and preparation method thereof | 北京东方雨虹防水技术股份有限公司 | 2024-12-17 | — | — | CN | claimed |
| CN-114573815-B | Quick-crosslinking-curing MQ type silicon resin and preparation method and application thereof | 杭州师范大学 | 2023-07-25 | — | — | CN | claimed |
| CN-115400269-B | Injectable bone cement and preparation method and application thereof | 武汉理工大学 | 2023-07-04 | — | — | CN | claimed |
| CN-114409903-B | Alpha-cyanoacrylate oxyethyl oxypropyl end-capped cross MDQ silicon resin, and preparation and application thereof | 杭州师范大学 | 2023-06-23 | — | — | CN | claimed |
| US-12606520-B2 | Calpain-2 inhibitor compounds and methods of treatment | WESTERN UNIVERSITY OF HEALTH SCIENCES (US) | 2026-04-21 | — | — | US | disclosed |
| CN-119144233-A | Non-cured rubber asphalt waterproof coating and preparation method thereof | 北京东方雨虹防水技术股份有限公司 | 2024-12-17 | — | — | CN | disclosed |
| CN-118461325-A | Carbon fiber sizing agent, preparation method thereof and composite material | 北京化工大学 | 2024-08-09 | — | — | CN | disclosed |
| EP-4392415-A1 | SUBSTITUTED AMINOPYRIDINE COMPOUNDS AS EGFR INHIBITORS | Yuhan Corporation (KR) | 2024-07-03 | — | — | EP | disclosed |
| EP-4370578-A1 | ACCELERATOR FOR EPOXY RESINS | Sika Technology AG (CH) | 2024-05-22 | — | — | EP | disclosed |
| US-11981658-B2 | Substituted aminopyridine compounds as EGFR inhibitors | YUHAN CORPORATION (KR) | 2024-05-14 | — | — | US | disclosed |
| CN-117980297-A | Substituted aminopyridine compounds as EGFR inhibitors | 柳韩洋行 | 2024-05-03 | — | — | CN | disclosed |
| EP-3568390-B1 | SMALL MOLECULE ACTIVATORS OF NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE (NAMPT) AND USES THEREOF | SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST (US) | 2024-03-06 | — | — | EP | disclosed |
| EP-0252992-A1 | Rubber-like polymers for tire treads, a process for their preparation, and compositions containing said polymers | Asahi Kasei Kogyo Kabushiki Kaisha (JP) | 1988-01-20 | — | — | EP | disclosed |
| US-4695405-A | Process for quenching fluorescence, and new cationic or amphoteric aromatic nitro compounds | BAYER AKTIENGESELLSCHAFT (DE) | 1987-09-22 | — | — | US | disclosed |
| EP-0217256-A2 | Method for quenching fluorescence, and cationic derivatives of naphthalene-peri-dicarboxamide | BAYER AG (DE) | 1987-04-08 | — | — | EP | disclosed |
| US-4624943-A | Aromatic basic-tailed vasopressin antagonists | SMITHKLINE BECKMAN CORPORATION (US) | 1986-11-25 | — | — | US | disclosed |
| EP-0195673-A2 | Aromatic basic-tailed vasopressin antagonists | SMITHKLINE BECKMAN CORPORATION (US) | 1986-09-24 | — | — | EP | disclosed |
| EP-0186817-A1 | 3(2H)pyridazinone, process for its preparation and anti-allergic agent containing it | NISSAN CHEMICAL INDUSTRIES LTD. (JP) | 1986-07-09 | — | — | EP | disclosed |
| EP-0163854-A2 | Process for the elimination of fluorescence and cationic or amphoteric aromatic nitro compounds | BAYER AG (DE) | 1985-12-11 | — | — | EP | disclosed |
| US-4208408-A | MUSCLE RELAXANTS | SANDOZ, INC. (US) | 1980-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12606520-B2 | Calpain-2 inhibitor compounds and methods of treatment | CAPN2, CAPN1, CAPNS1 | HRH3 2482/4885ALDH1A1 3630/4885TSHR 4532/4885 |
| US-11981658-B2 | Substituted aminopyridine compounds as EGFR inhibitors | EGFR, ERBB2, ERBB4 | HRH3 1862/4885ALDH1A1 2639/4885TSHR 2939/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.